Contact Center Solutions Industry News

[March 08, 2006]

Shionogi, Galderma to Promote Acne Medicine Adapalene in Japan

(Comtex Business Via Thomson Dialog NewsEdge)Tokyo, Japan, Mar 08, 2006 (JCN Newswire via COMTEX) --Shionogi announced on March 7 that it has reached a basic agreement with Galderma K.K. for the sale of adapalene gel 0.1%, Galderma's proprietary agent for the treatment of acne.

Under the terms of the agreement, the two companies will collaborate in promoting the agent upon its receipt of manufacturing approval in Japan. Further, Shionogi will retain the exclusive right to sell the agent for eight years after its release.

Adapalene gel 0.1%, a naphthoic acid derivative with retinoid-like activity, is prescribed in over 80 countries worldwide under the trade name Differin. Galderma K.K. has recently completed phase III controlled studies in Japan and plans to file a new drug application with the Ministry of Health, Labor and Welfare in the second quarter 2006.

[ Back To Contact Center Solutions Homepage's Homepage ]



Related Contact Center Solutions Articles

Socialize with us

FREE Contact Center Solutions eNewsletter

Click here to receive your targeted Contact Center Solutions Community eNewsletter.[Subscribe Now]

Contact Center Solutions Glossary of Terms

About the Contact Center Solutions Community

    Welcome to the Contact Center Solutions Community The Contact Center Solutions Global Online Community, Sponsored by Interactive Intelligence, is designed to serve as the industry's premier resource for information and research on Contact Center Solutions technology and deployment strategies.